+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Mexico Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 61 Pages
  • July 2026
  • Region: Mexico
  • Mordor Intelligence
  • ID: 5175484
Mexico ophthalmic devices market size in 2026 is estimated at USD 1.25 billion, growing from 2025 value of USD 1.19 billion with 2031 projections showing USD 1.58 billion, growing at 4.83% CAGR over 2026-2031. This report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, and More), End-User (Hospitals, Specialty Ophthalmic Clinics, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Mexico Ophthalmic Devices Market Trends and Insights

Escalating Diabetic Retinopathy Burden

One in three Mexican adults with type 2 diabetes shows retinal damage that requires routine optical coherence tomography and fundus photography. Screening efficiency is high, with one positive case detected for every three patients evaluated, a ratio that justifies large equipment orders for public hospitals.

Federal “Salud Visual” and MAS-Bienestar Programs

The national health platform offers free primary eye care, while the “Vive Saludable, Vive Feliz” initiative screens 11 million schoolchildren for refractive errors. Mandatory electronic health records route patients to accredited centers, prompting procurement of interoperable autorefractors and pediatric diagnostic kits.

Limited Reimbursement for Premium IOLs

Public insurance excludes multifocal and light-adjustable lenses, so patients finance upgrades themselves. A standard cataract intervention costs USD 1,045, which is a heavy burden for many households.

Other drivers and restraints analyzed in the detailed report include:

  • Expansion of High-Volume Private Ophthalmology Chains
  • Smartphone-Related Myopia Surge among Youth
  • Shortage of Trained Ophthalmic Surgeons

Segment Analysis

Vision care generated 64.62% of overall revenue in 2025 as domestic factories supply low-cost spectacles and contact lenses. EssilorLuxottica’s USD 172 million Tijuana complex fabricates 10 million pairs annually, positioning the plant as a regional export hub Essilorluxottica.com. The Mexico ophthalmic devices market size for vision care is projected at USD 1.01 billion by 2031 alongside a steady replacement cycle.

Diagnostic and monitoring devices record the fastest trajectory with a 6.72% CAGR through 2031. Artificial-intelligence modules inside OCT scanners boost reading accuracy to 88.6%, surpassing early-career clinicians. Government diabetes initiatives add community clinics to the upgrade roster, pushing the Mexico ophthalmic devices market to install compact fundus cameras that upload images to cloud repositories.

Complete Report Scope:

  • By Device Type
    • Diagnostic & Monitoring Devices
      • OCT Scanners
      • Fundus & Retinal Cameras
      • Autorefractors & Keratometers
      • Corneal Topography Systems
      • Ultrasound Imaging Systems
      • Perimeters & Tonometers
      • Other Diagnostic & Monitoring Devices
    • Surgical Devices
      • Cataract Surgical Devices
      • Vitreoretinal Surgical Devices
      • Refreactive Surgical Devices
      • Glaucoma Surgical Devices
      • Other Surgical Devices
    • Vision Care Devices
      • Spectacles Frames & Lenses
      • Contact Lenses
  • By Disease Indication
    • Cataract
    • Glaucoma
    • Diabetic Retinopathy
    • Other Disease Indications
  • By End-user
    • Hospitals
    • Specialty Ophthalmic Clinics
    • Ambulatory Surgery Centers (ASCs)
    • Other End-users

List of Companies Covered in this Report:

  • Alcon
  • Johnson & Johnson Vision Care, Inc.
  • Bausch + Lomb Corporation
  • EssilorLuxottica
  • Carl Zeiss
  • Topcon
  • Nidek
  • HOYA
  • The Cooper Companies
  • Glaukos
  • STAAR Surgical
  • HAAG-Streit
  • Lumibird Medical
  • Visionix Ltd.
  • Heidelberg Engineering
  • Canon

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Diabetic Retinopathy & Age-Related Cataract in Mexico
4.2.2 Government 'Salud Visual' Program Boosting Surgical Volumes
4.2.3 Expansion of Private Ophthalmology Chains in Urban Hubs
4.2.4 Smartphone-Driven Myopia Surge among Mexican Youth
4.2.5 Adoption of Femtosecond & SLT Lasers Post-COFEPRIS Approvals
4.2.6 Medical-Tourism Demand for Premium IOLs in Border States
4.3 Market Restraints
4.3.1 Limited Reimbursement for Premium IOLs & Refractive Procedures
4.3.2 Shortage of Trained Ophthalmic Surgeons in Rural Regions
4.3.3 Import Tariffs & Lengthy COFEPRIS Registration Timelines
4.3.4 Peso Depreciation Inflates Cost of Imported Equipment
4.4 Regulatory Landscape
4.5 Porter's Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitutes
4.5.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 OCT Scanners
5.1.1.2 Fundus & Retinal Cameras
5.1.1.3 Autorefractors & Keratometers
5.1.1.4 Corneal Topography Systems
5.1.1.5 Ultrasound Imaging Systems
5.1.1.6 Perimeters & Tonometers
5.1.1.7 Other Diagnostic & Monitoring Devices
5.1.2 Surgical Devices
5.1.2.1 Cataract Surgical Devices
5.1.2.2 Vitreoretinal Surgical Devices
5.1.2.3 Refreactive Surgical Devices
5.1.2.4 Glaucoma Surgical Devices
5.1.2.5 Other Surgical Devices
5.1.3 Vision Care Devices
5.1.3.1 Spectacles Frames & Lenses
5.1.3.2 Contact Lenses
5.2 By Disease Indication
5.2.1 Cataract
5.2.2 Glaucoma
5.2.3 Diabetic Retinopathy
5.2.4 Other Disease Indications
5.3 By End-user
5.3.1 Hospitals
5.3.2 Specialty Ophthalmic Clinics
5.3.3 Ambulatory Surgery Centers (ASCs)
5.3.4 Other End-users
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Alcon Inc.
6.3.2 Johnson & Johnson Vision Care, Inc.
6.3.3 Bausch + Lomb Corporation
6.3.4 EssilorLuxottica SA
6.3.5 Carl Zeiss Meditec AG
6.3.6 Topcon Corporation
6.3.7 Nidek Co., Ltd.
6.3.8 HOYA Corporation
6.3.9 CooperVision, Inc.
6.3.10 Glaukos Corporation
6.3.11 STAAR Surgical Company
6.3.12 Haag-Streit Group
6.3.13 Lumibird Medical
6.3.14 Visionix Ltd.
6.3.15 Heidelberg Engineering GmbH
6.3.16 Canon Medical Systems Corp.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alcon Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Bausch + Lomb Corporation
  • EssilorLuxottica SA
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Nidek Co., Ltd.
  • HOYA Corporation
  • CooperVision, Inc.
  • Glaukos Corporation
  • STAAR Surgical Company
  • Haag-Streit Group
  • Lumibird Medical
  • Visionix Ltd.
  • Heidelberg Engineering GmbH
  • Canon Medical Systems Corp.